Novozymes Moves Cell Culture Ingredients Activities from Australia

Novozymes says its Novozymes Biopharma AU (Adelaide, Australia) subsidiary has decided to move all its activities to Novozymes’ sites at Bagsværd, Denmark and Nottingham, U.K. This consolidation will streamline the company’s research and development setup within industrial cell culture ingredients and allow for a more focused and cost effective approach to the cell culture ingredients market, Novozymes says. The majority of the reorganization will be completed by the end of this year, and it will result in layoffs in Australia, the company says...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers